Gilead Says Its Coronavirus Drug Lowers The Risk Of Death; Shares Pop

Gilead Says Its Coronavirus Drug Lowers The Risk Of Death; Shares Pop

Gilead Sciences said Friday its experimental coronavirus treatment, known by the test name remdesivir, lowered the risk of death by 62% in a Phase 3 study — prodding GILD stock higher.